Targeted alpha anticancer therapies: update and future prospects
Barry J Allen,1,2 Chen-Yu Huang,3 Raymond A Clarke2 1Faculty of Physics, University of Sydney, Sydney, NSW, Australia; 2Faculty of Medicine, Ingham Institute, University of Western Sydney, Liverpool, NSW, Australia; 3Central Clinical School, University of Sydney, Sydney, NSW, AustraliaAbstract: Tar...
Saved in:
Main Authors: | Allen BJ, Huang CY, Clarke RA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/2e454f40cb7b41de9c24a7b890990185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current applications and future prospects of nanomaterials in tumor therapy
by: Huang Y, et al.
Published: (2017) -
Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug
by: Wang H, et al.
Published: (2014) -
Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug
by: Lin CY, et al.
Published: (2012) -
Update on sepsis-associated acute kidney injury: emerging targeted therapies
by: Doyle JF, et al.
Published: (2016) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
by: Irina Petrache, et al.
Published: (2009)